Aims and Scope
Aims:
WebLog Journal of Oncology is an open-access, peer-reviewed journal dedicated to cancer biology, translational oncology, precision therapeutics, and multidisciplinary clinical cancer care. The journal publishes evidence that advances early detection, treatment selection, response monitoring, survivorship planning, and long-term patient outcomes across diverse malignancies.
The scope includes solid tumors and hematologic cancers, molecular tumor profiling, immuno-oncology, targeted therapies, endocrine and cytotoxic treatment strategies, radiation oncology, surgical oncology, and supportive and palliative oncology pathways. Submissions that integrate mechanistic findings with clinically actionable implications are strongly encouraged.
Priority is given to studies on biomarker-guided therapy, resistance biology, tumor microenvironment dynamics, minimal residual disease assessment, real-world oncology outcomes, and quality-of-life endpoints. The journal also welcomes work on cancer prevention, hereditary risk, screening effectiveness, and implementation of precision oncology in routine care settings.
Interdisciplinary cancer-care research is central to the journal, including pathology-radiology-oncology collaboration, tumor board-informed decision systems, digital oncology workflows, and equitable access to advanced diagnostics and treatment. Pediatric, adolescent-young adult, and geriatric oncology research is within scope.
Authors benefit from a rapid and transparent editorial process, with first decision typically within 21 days and publication generally within 7-10 days after acceptance. Articles are published under a Creative Commons license, assigned a permanent DOI, and disseminated through major scholarly discovery channels including OpenAIRE and Google Scholar, with long-term archival preservation in Zenodo and QR-enabled article access.
Accepted article types include Research Article, Review Article, Systematic Review, Short Communication, Case Report, Clinical Image, Editorial, Perspective, and Letter to the Editor. All submissions undergo rigorous peer review by oncology experts to ensure scientific integrity, methodological rigor, and meaningful relevance for cancer research and practice.
Scope:
WebLog Journal of Oncology widely accepts manuscripts in the following areas, but is not limited to: